A Win For ImmunityBio Inc.
Fri, Apr 26, 2024 at 07:14 PM
ImmunityBio Inc. (IBRX:NASDAQ) shot up at $7.35, a gain of 43.8%. On Fri, Apr 26, 2024, IBRX:NASDAQ touched a New 2-Week High of $7.35. The stock got featured on our News Catalysts scanner on Thu, Apr 25, 2024 at 04:34 AM in the 'BIOTECH' category. From Fri, Apr 12, 2024, the stock recorded 60.00% Up Days and 45.45% Green Days
About ImmunityBio Inc. (IBRX:NASDAQ)
ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases.
Top 10 Gainers:
- Vinco Ventures Inc. (BBIG:NASDAQ), 233.33%
- Biodexa Pharmaceuticals plc Sponsored ADR (New) 2023 (BDRX:NASDAQ), 80.56%
- Arrowroot Acquisition Corp. (ARRW:NASDAQ), 54.64%
- ImmunityBio Inc. (IBRX:NASDAQ), 43.84%
- Agenus Inc. (AGEN:NASDAQ), 40.84%
- Universal Logistics Holdings, Inc. (ULH:NASDAQ), 39.37%
- Connexa Sports Technologies Inc. (CNXA:NASDAQ), 38.89%
- NewGenIvf Group Limited (NIVF:NASDAQ), 36.92%
- Katapult Holdings Inc. (KPLT:NASDAQ), 35.74%
- Mobix Labs Inc. (MOBX:NASDAQ), 33.59%